Amgen, INC.
biopharmaceutical company
Based in DC
🤖
AI Overview
With $1.7M in lobbying spend across 29 quarterly filings, Amgen, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2019 to 2025.
$1.7M
Total Spend
7
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $240K |
| 2020 | $240K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Immigration
- •Healthcare policy issues as they relate to the pharmaceutical industry including prescription drug value issues, FDA and biosimilars.
- •Monitoring issues related to drug pricing and Medicare Part D.
- •Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars.
- •Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Ascension Health Alliance D/B/A Ascension
$12.8M total spend
National Rural Health Assocation
$2.2M total spend
American Hospital Association
$1.8M total spend
American Association of Child & Adolescent Psychiatry
$1.6M total spend
Tiber Creek Health Strategies, INC. (on Behalf of Eli Lilly and Company)
$1.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.